The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats

Biopharmaceutics and Drug Disposition

Volumn 35, Issue 6, 2014, Pages 330-340

  Wiczling, Paweł ^a   Krzyzanski, Wojciech ^b   Zychlińska, Natalia ^a   Lewandowski, Krzysztof ^a   Kaliszan, Roman ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Age distribution; Erythropoietin; Flow cytometry; Neocytolysis; Reticulocytes dynamics

Indexed keywords

BILIRUBIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; THIAZOLE ORANGE; ERYTHROPOIETIN; RECOMBINANT PROTEIN;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ARTICLE; BLOOD; BONE MARROW; CELL MATURATION; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROPOIESIS; FLOW CYTOMETRY; HEMOGLOBIN DETERMINATION; NEOCYTOLYSIS; NONHUMAN; RAT; RETICULOCYTE; RETICULOCYTE COUNT; SPLEEN; ANIMAL; BONE MARROW CELL; CYTOLOGY; DRUG EFFECTS; ERYTHROCYTE COUNT; HOMEOSTASIS; MALE; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BILIRUBIN; BONE MARROW CELLS; ERYTHROCYTE COUNT; ERYTHROPOIESIS; ERYTHROPOIETIN; FLOW CYTOMETRY; HEMOGLOBINS; HOMEOSTASIS; MALE; RATS, WISTAR; RECOMBINANT PROTEINS; RETICULOCYTES; SPLEEN;

EID: 84922263088     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.1902     Document Type: Article

References (35)

1. Ney PA. Normal and disordered reticulocyte maturation. Curr Opin Hematol 2011; 18: 152-157.
2. Gronowicz G, Swift H, Steck TL. Maturation of the reticulocyte in vitro. J Cell Sci 1984; 71: 177-197.
3. Koury MJ, Koury ST, Kopsombut P, Bondurant MC. In vitro maturation of nascent reticulocytes to erythrocytes. Blood 2005; 105: 2168-2174.
4. Noble NA, Xu QP, Ward JH. Reticulocytes. I. Isolation and in vitro maturation of synchronized populations. Blood 1989; 74: 475-481.
5. Wiczling P, Krzyzanski W. Flow cytometric assessment of homeostatic aging of reticulocytes in rats. Exp Hematol 2008; 36: 119-127.
6. Ganzoni A, Hillman RS, Finch CA. Maturation of the macroreticulocyte. Br J Haematol 1969; 16: 119-135.
7. Tarbutt RG. Cell population kinetics of the erythroid system in the rat. The response to protracted anaemia and to continuous gamma-irradiation. Br J Haematol 1969; 16: 9-24.
8. Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 2000; 37: 93-130.
9. Wiczling P, Ait-Oudhia S, Krzyzanski W. Flow cytometric analysis of reticulocyte maturation after erythropoietin administration in rats. Cytometry A 2009; 75: 584-592.
10. Wiczling P, Krzyzanski W. Method of determination of the reticulocyte age distribution from flow cytometry count by a structured-population model. Cytometry A 2007; 71: 460-467.
11. Robinson SH, Tsong M. Hemolysis of 'stress' reticulocytes: a source of erythropoietic bilirubin formation. J Clin Invest 1970; 49: 1025-1034.
12. Jandl JH. The agglutination and sequestration of immature red cells. J Lab Clin Med 1960; 55: 663-681.
13. Dornfest BS, Handler ES, Handler EE. Reticulocyte sequestration in spleens of normal, anaemic and leukaemic rats. Br J Haematol 1971; 21: 83-94.
14. Sorbie J, Valberg LS. Splenic sequestration of stress erythrocytes in the rabbit. Am J Physiol 1970; 218: 647-653.
15. Noble NA, Xu QP, Hoge LL. Reticulocytes II: reexamination of the in vivo survival of stress reticulocytes. Blood 1990; 75: 1877-1882.
16. Alfrey CP, Fishbane S. Implications of neocytolysis for optimal management of anaemia in chronic kidney disease. Nephron Clin Pract 2007; 106: c149-c156.
17. Alfrey CP, Rice L, Udden MM, Driscoll TB. Neocytolysis: physiological down-regulator of red-cell mass. Lancet 1997; 349: 1389-1390.
18. Chang CC, Chen Y, Modi K, Awar O, Alfrey C, Rice L. Changes of red blood cell surface markers in a blood doping model of neocytolysis. J Investig Med 2009; 57: 650-654.
19. Rice L, Alfrey CP. Modulation of red cell mass by neocytolysis in space and on Earth. Pflugers Arch 2000; 441: R91-R94.
20. Rice L, Alfrey CP. The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cell Physiol Biochem 2005; 15: 245-250.
21. Rice L, Alfrey CP, Driscoll T, Whitley CE, Hachey DL, Suki W. Neocytolysis contributes to the anemia of renal disease. Am J Kidney Dis 1999; 33 : 59-62.
22. Rice L, Ruiz W, Driscoll T, et al. Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass. Ann Intern Med 2001; 134: 652-656.
23. Trial J, Rice L, Alfrey CP. Erythropoietin withdrawal alters interactions between young red blood cells, splenic endothelial cells, and macrophages: an in vitro model of neocytolysis. J Investig Med 2001; 49: 335-345.
24. http://www.mathworks.com/matlabcentral/fileexchange/37881-flowplot/content/FlowPlot/fcsread.m.
25. Woo S, Krzyzanski W, Jusko WJ. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats. J Pharmacol Exp Ther 2006; 319: 1297-1306.
26. Derelanko MJ. Determination of erythrocyte life span in F-344, Wistar, and Sprague-Dawley rats using a modification of the [3H]diisopropylfluorophosphate ([3H]DFP) method. Fundam Appl Toxicol 1987; 9: 271-276.
27. Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med 1985; 26: 72-76.
28. Song SH, Groom AC. Sequestration and possible maturation of reticulocytes in the normal spleen. Can J Physiol Pharmacol 1972; 50: 400-406.
29. Koury MJ, Bondurant MC. The molecular mechanism of erythropoietin action. Eur J Biochem 1992; 210: 649-663.
30. Molineux G, Foote M, Elliott SG. Erythropoietins and Erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology. Birkhöuser Verlag: Basel, New York, 2003; xi, 269 pp.
31. Wick TM, Moake JL, Udden MM, McIntire LV. Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells. Am J Hematol 1993; 42: 284-292.
32. Ribatti D, Presta M, Vacca A, et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999; 93: 2627-2636.
33. Woo S, Krzyzanski W, Jusko WJ. Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO). J Pharmacokinet Pharmacodyn 2007; 34: 849-868.
34. Ait-Oudhia S, Scherrmann JM, Krzyzanski W. Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats. J Pharmacol Exp Ther 2010; 334: 897-910.
35. Krzyzanski W, Brier ME, Creed TM, Gaweda AE. Reticulocyte-based estimation of red blood cell lifespan. Exp Hematol 2013; 41: 817-822.